Ethical Performance
inside intelligence for responsible business
 

news

Roche agrees HIV therapy deals

October 2008

The Roche pharmaceuticals company has entered into four new technology transfers with manufacturers in Bangladesh and three African countries where better access to HIV therapy is needed.

Under the agreement Beximar Pharmaceuticals in Bangladesh and manufacturers in Kenya, Tanzania and Zimbabwe will receive free technical expertise to make generic HIV medicine, based on the processes used by Roche to produce saquinavir.

Roche teams will work at all four factories and from the company’s headquarters in Switzerland to undertake the technology transfers.

William Burns, Roche Pharma’s chief executive, said the company was hoping to ‘strengthen and expand local manufacturing capabilities for HIV medicines in resource-limited countries’.

In addition to the four agreements Roche has expanded the Technology Transfer Initiative with training seminars for companies in developing countries. The emphasis will be on improved manufacturing processes.




Roche | Global | HIV/Aids

Further Information
http://www.roche-hiv.com
http://www.roche.com/sus_med.htm
BBMG1

3BL Media News
Membership
Sign up for Free e-news
Report Alerts
Job Vacancies
eNews
Events Updates
Best Practice Newsletter